News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amid Strong Demand, Illumina, Inc. (ILMN) CEO Sees Need for More "Tuck-In" Deals


7/25/2013 8:38:47 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shares of San Diego-based Illumina (NASDAQ: ILMN) climbed today by more than $7 a share, or roughly 10 percent, after the gene sequencing equipment maker posted quarterly results that exceeded Wall Street expectations. The stock was above $81 a share in heavy trading this afternoon. Illumina reported its seventh consecutive quarter of sequential revenue growth—driven by strong global demand for its HiSeq instruments used in genetic sequencing and related consumable supplies.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES